USA Rare Earth Inc
7 nominees · 2 ballot items.
Two proposals are on the ballot: Proposal 1 - Warrant Share Issuance Proposal to issue up to 10,714,286 shares of Common Stock under a Common Warrant; Proposal 2 - Adjournment Proposal to adjourn the meeting if needed to solicit additional proxies.
Follow how the vote landed and what changed on USA Rare Earth Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
Warrant Share Issuance Proposal
ManagementBoard: FORApproval of the issuance of up to 10,714,286 shares of our common stock pursuant to a Common Warrant issued to an institutional investor in connection with the private placement closed May 2, 2025.
- 2
Adjournment Proposal
ManagementBoard: FORApproval to adjourn the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event there are insufficient votes for or in connection with the approval of the Warrant Share Issuance Proposal.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Alyeska Investment Group, L.P. | 7.4% | 16,570,777 | $251M |
| 2 | STATE STREET CORP | 5.4% | 12,065,748 | $183M |
| 3 | Bayshore Capital Advisors, LLC | 3.9% | 8,743,216 | $132M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 8,361,996 | $127M |
| 5 | BlackRock, Inc. | 3.1% | 6,972,281 | $106M |
| 6 | BlackRock, Inc. | 2.3% | 5,208,818 | $79M |
| 7 | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2.2% | 4,854,970 | $73M |
| 8 | Hood River Capital Management LLC | 1.9% | 4,242,941 | $79M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 3,695,528 | $56M |
| 10 | UBS Group AG | 1.6% | 3,562,869 | $54M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at USA Rare Earth Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the USA Rare Earth Inc 2025 special meeting?
- USA Rare Earth Inc (USAR) holds its 2025 special shareholder meeting on Tuesday, July 1, 2025.
- What is the record date for the USA Rare Earth Inc 2025 meeting?
- The record date for the USA Rare Earth Inc 2025 meeting is Friday, May 23, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for USA Rare Earth Inc's 2025 meeting?
- The board is presenting 7 director nominees at the USA Rare Earth Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the USA Rare Earth Inc 2025 meeting?
- Shareholders will vote on 2 proposals at the USA Rare Earth Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.